1,015.5 816.4 80.4 Deficit from business combination under common control (22.9) (22.9) - - Total equity 10,793.0 5,571.6 5,221.4 93.7 31 December Statement of Financial Position Change 3. Analysis of
. Several claimants sharing a like claim against the respondent on the common grounds of laws and facts against the respondent may jointly file the dispute to the Office, provided that each claimant seeks
dispute. Clause 8. Several claimants sharing a like claim against the respondent on the common grounds of laws and facts against the respondent may jointly file the dispute to the Office, provided that each
transaction occurred. 2) In case of free transfer fee and common area fee (if any) are considered payable to customers or expenses paid for the customers and therefore shall be treated as a reduction of the
6.42% Liabilities 372.39 283.75 88.64 31.24% Shareholders' equity 643.70 671.07 (27.37) (4.08%) Issued and fully paid-up common share (Million Share) 565.14 565.14 0.00 0.00% Par (Baht) 0.50 0.50 0.00
the consolidation of Rabbit Group under the common control basis. 1Adjusted for gain of fair value measurement in MACO at acquisition date, share of investment in JV and associates and non-recurring
capital 231.0 2,497.0 Retained earnings 3,011.3 2,508.7 Surplus on business combination under common control 328.0 353.1 Other components of SE -239.5 -429.5 Non-Controlling Interest 108.6 202.9 Total
Being a person under Section 258 of the Managing Director of SCT 2. Chokwatana Co., Ltd. 140,620 0.12 Major shareholder of SPI which held 16.80% of total issued and paid-up shares of SPI Have 3 common
shares of SPI Have 3 common directors with SPI who are Mr. Boonsithi Chokwatana, Mr. Boonchai Chokwatana, and Mr. Boonkiet Chokwatana 3. International Laboratories Corp., Ltd. 186,500 0.16 Have 30.27